A
$ Value
$0
Shares
292,983
Price
$0
Filed
May 23
Insider
Name
FALBERG KATHRYN E
Title
—
CIK
0001206977
Roles
Director
Transaction Details
Transaction Date
2025-05-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
292,983
Footnotes
100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Filing Info
FALBERG KATHRYN E's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | TTD | D | $0 |
| 2026-03-23 | TTD | D | $13K |
| 2026-03-23 | TTD | D | $18K |
| 2026-03-23 | TTD | D | $13K |
| 2026-03-05 | TTD | ▼ | $3.1M |
| 2026-03-05 | TTD | ▼ | $1.5M |
| 2025-06-10 | RCUS | A | $0 |
| 2025-06-10 | RCUS | A | $0 |
| 2025-05-27 | TTD | A | $0 |
| 2025-05-27 | TTD | A | $50K |
Other Insiders at NUVB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hung David
PRESIDENT AND CEO
|
— | — | 2026-02-27 |
|
Wentworth Kerry
CHIEF REGULATORY OFFICER
|
— | $1.1M | 2026-04-17 |
| Cui Xiangmin | — | — | 2026-02-27 |
|
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-27 |
|
Markel Stacy
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-27 |
|
Hanley David C.
CHIEF TECHNICAL OPERATIONS
|
— | — | 2026-02-27 |
|
Liu Dongfang
CHIEF MEDICAL OFFICER
|
— | $251K | 2026-04-17 |
|
Makunje Moses
SEE REMARKS
|
— | — | 2026-02-27 |
|
Sjogren Colleen
Chief Commercial Officer
|
— | — | 2026-02-27 |
|
Sauvage Philippe
Chief Financial Officer
|
— | — | 2026-02-27 |